Associated Papers
Multidimensional quantitative phenotypic and molecular analysis reveals neomorphic behaviors of p53 missense mutants.
Pal A et al.
Npj Breast Cancer, 2023
37773066 (PubMed )
Supplement: 41523_2023_582_MOESM1_ESM.pdf
Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation.
Naus E et al.
Cells, 2023
Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe.
Asl ER et al.
Life Sciences, 2023
Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.
Semenov O et al.
Frontiers in Molecular Biosciences, 2022
Diverse and cancer type‑specific roles of the p53 R248Q gain‑of‑function mutation in cancer migration and invasiveness.
Olszewski MB et al.
International Journal of Oncology, 2019
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.
Iwanicki MP et al.
Jci Insight, 2016
p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components.
Lien HC et al.
The Journal of Pathology, 2004
Select a paper to view details